| (INR) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 23.88B | — |
| Operating expense | — | — |
| Net income | 2.99B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, IPCALAB.NS returned +35.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +35.2% |
| 1 year | +35.2% |
| 5 years | +51.9% |
| 10 years | +632.8% |
| All-time high | ₹1,920.40 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₹1,000 in IPCALAB.NS would be worth today ›Yes. Ipca Laboratories Limited paid 1 dividend over the past 12 months. The most recent was ₹6.00 per share on Aug 7, 2026. The dividend yield is 0.31%.
Ipca Laboratories Limited is part of the Healthcare sector.
Ipca Laboratories Limited has a market cap of 487.21B INR, based on the latest quote.
Ipca Laboratories Limited is expected to report earnings around Nov 12, 2026. That date is an estimate and has not been confirmed by the company.
